前交叉韧带联合前外侧韧带重建与单纯前交叉韧带重建的长期移植物断裂率比较:SANTI研究组倾向匹配分析
本研究为队列研究(证据等级3),将2011年1月至2012年3月接受初次前交叉韧带联合前外侧韧带重建(ACL+ALLR)的患者与同期单纯ACL重建(ACLR)患者按1:1倾向匹配,平均随访104.33个月。
要点
- ACL+ALLR组再手术率(15.3% vs 32.6%)和翻修ACLR率(3.5% vs 17.4%)均显著更低(P<.05)。
核心结论
- 与单纯ACLR相比,ACL+ALLR可显著改善长期ACL移植物生存率、降低再手术率,且不增加并发症。
- 单纯ACLR患者平均随访104.3个月时行翻修手术的风险增加5倍以上。
研究设计与样本
- 队列研究,证据等级3。
- 2011年1月至2012年3月接受初次ACL+ALLR的患者与同期单纯ACLR患者按1:1倾向匹配,共纳入86对匹配患者。
- ACL+ALLR组平均年龄32.2±8.8岁(范围22-67岁),单纯ACLR组34.7±8.5岁(范围21-61岁)。
- 平均随访104.33±3.74个月(范围97-111个月),采用面对面和远程医疗随访,末次随访于2020年3月。
- 使用Kaplan-Meier分析评估移植物生存率,Logistic回归校正活动水平的潜在影响。
主要发现
- ACL+ALLR组总体再手术率为15.3%,单纯ACLR组为32.6%(P<.05)。
- ACL+ALLR组翻修ACLR率为3.5%,单纯ACLR组为17.4%(P<.05)。
- 两组在其他并发症及患者报告结局指标(KOOS、IKDC、Lysholm、Tegner评分)上无显著差异。
关键数值与推荐
- 总体再手术率:ACL+ALLR组15.3% vs 单纯ACLR组32.6%(P<.05)。
- 翻修ACLR率:ACL+ALLR组3.5% vs 单纯ACLR组17.4%(P<.05)。
临床怎么用
- 对于初次ACL重建患者,联合前外侧韧带重建可显著降低长期移植物断裂和翻修手术风险。
- 联合手术不增加并发症,且患者报告结局与单纯ACLR相当,可作为降低失败率的术式选择。
局限性
- 本研究为队列研究(证据等级3),非随机对照试验。
- 样本量有限(86对匹配患者),随访时间平均约104个月,仍需更长期数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Clinical studies have demonstrated significant advantages of combined anterior cruciate ligament and anterolateral ligament reconstruction (ACL+ALLR) over isolated ACL reconstruction (ACLR) with respect to reduced graft rupture rates, a lower risk of reoperation for secondary meniscectomy, improved knee stability, and higher rates of return to sports. However, no long-term studies exist. PURPOSE/HYPOTHESIS: The purpose of this study was to compare the outcomes of isolated ACLR versus ACL+ALLR at long-term follow-up. The hypothesis was that patients who underwent combined procedures would experience significantly lower rates of graft rupture. STUDY DESIGN: Cohort study; Level of evidence, 3. METHODS: Patients undergoing primary ACL+ALLR between January 2011 and March 2012 were propensity matched in a 1:1 ratio to patients who underwent isolated ACLR during the same period. A combination of face-to-face and telemedicine postoperative follow-up was undertaken. At the end of the study period (March 2020), medical notes and a final telemedicine interview were used to determine whether patients had experienced any complications or reoperations. The Knee injury and Osteoarthritis Outcome Score, International Knee Documentation Committee score, Lysholm score, and Tegner score were collected for all patients. Graft survivorship was assessed using Kaplan-Meier analysis. Logistic regression was performed to account for the potential effect of activity level on graft rupture rates. RESULTS: A total of 86 matched pairs were included in the study. The mean ± SD age was 32.2 ± 8.8 years (range, 22-67 years) in the ACL+ALLR group and 34.7 ± 8.5 years (range, 21-61 years) in the isolated ACLR group. The mean duration of follow-up was 104.33 ± 3.74 months (range, 97-111 months). Patients who underwent combined ACL+ALLR versus isolated ACLR experienced significantly better ACL graft survivorship (96.5% vs 82.6%, respectively; P = .0027), lower overall rates of reoperation (15.3% vs 32.6%; P < .05), and lower rates of revision ACLR (3.5% vs 17.4%; P < .05). Patients undergoing isolated ACLR were at >5-fold greater risk of graft rupture (odds ratio, 5.549; 95% CI, 1.431-21.511; P = .0132), regardless of their preinjury activity level. There were no significant differences between groups with respect to other complications or any clinically important differences in patient-reported outcome measures. CONCLUSION: Patients who underwent combined ACL+ALLR experienced significantly better long-term ACL graft survivorship, lower overall rates of reoperation, and no increase in complications compared with patients who underwent isolated ACLR. Further, patients who underwent isolated ACLR had a >5-fold increased risk of undergoing revision surgery at a mean follow-up of 104.3 months.
引用
- Sonnery-Cottet B, Haidar I, Rayes J, et al. Long-term Graft Rupture Rates After Combined ACL and Anterolateral Ligament Reconstruction Versus Isolated ACL Reconstruction: A Matched-Pair Analysis From the SANTI Study Group. Am J Sports Med. 2021. PMID: 34351825. doi:10.1177/03635465211028990
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。